Gebelik ve hiperkoagülabilite
Yıl: 2001 Cilt: 8 Sayı: 1 Sayfa Aralığı: 40 - 47 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
Gebelik ve hiperkoagülabilite
Öz: -
Anahtar Kelime: Konular:
Pregnancy and hypercoagulability
Öz: -
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Mc Coll MD, Walker ID, Greer IA. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy. Br J Obstet Gynaecol 1999; 106: 756-66.
- 2. Hellgren M. Hemostasis in normal pregnancy and puerperium. Haemostasis 1999; 26(Suppl 4): 244-7.
- 3. Stirling Y, Woolf L, North WRS, et al. Haemostasis in normal pregnancy. Thromb Haemostas 1984; 52: 176-82.
- 4. Ridgker PM, Miletich IP, Buring IE, et al. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998; 128: 1000-3.
- 5. Lissak A, Sharon A, Fruchter O, et al. Polymorphism of mutation of cytosine to thymine at location .677 in three methylen etetrahydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol 1999; 181: 126-30.
- 6. Kupferminc MI, Eldor A, Steinman N, et al. Increasedfrequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
- 7. Ginsberg I, Brill-Edwards IS, Burrows RF, et al. Venous thrombosis during pregnancy: Leg and trimestir of presentation. Thromb Haemostas 1992; 67: 519-20.
- 8. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated. Protein C Nature 1994; 364-9.
- 9. Poort SR, Rosendaal FR, Reitsma PH. A common genetic variation in the 3 '-untranslated region of the prothrombin gene is associated with elevated proth-rombin levels and increase in venous thrombosis. Blood 1996; 88: 3698-402.
- 10. Frosst P, Blom HI, Milos R. A candidate genetic risk factor for vascular disease: A common mutation in methylene tetrahidrofolate reductase. Nat Genet 1995; 10:111-7.
- 11. Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-26.
- 12. Dahlback B, Carlsson M, Svenson PI. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: Predilection of a cofactor to activated. Protein C Prot Nat Acad Sci 1993; 90: 1004-8.
- 13. Rosendaal FR. Venous thrombosis: A multicausal di-sease. Lancet 1999; 353:1167-73.
- 14. Greer IA. Thrombosis in pregnancy: Maternal and fetal issues. Lancet 1999; 353:1258-65.
- 15. Walker ID. Management of thrombophilia in pregnancy. Blood Reviews 1991; 5: 227-33.
- 16. Walker ID. Congenital thrombophilia Bailliere's Clinical. Obstetrics and Gynaecology 1997; 11: 431-45.
- 17. Vinazzer H. Hereditary and acquired antithrombin deficiency. Sem Thromb Hemost 1999; 25: 361-7.
- 18. Girling I, Swiet M. Acquired thrombophilia. Bailliere's Clinical Obstetrics and Gynaecology 1992; 11: 447-62.
- 19. Friederich WP, Sanson BJ, Simioni P, et al. Frquency of pregnancy related venoud thromboembolism in an-ticoagulant factor-deficient women: Implications for prophylaxis. Ann Intern Med 1996; 125: 955-60.
- 20. Koster T, Rosendaal FR, Ronde H. Venous thrombosis due to oor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-10.
- 21. Bokarewa Ml, Bremme K, Blomback M. Arg 506- GLN mutation in Factor V and risk of thrombosis during pregnancy. Br J Haematol 1996; 92: 473-8.
- 22. Dahlback B. Activated protein C resistance and thrombosis: Molecular mechanisms of hypercoagulable state due to FVR506Q mutation. Sem Thromb Hemost. 1999; 25: 273-320.
- 23. Gerhardt A, Scharf RE, Beckman BE, et al. Prothrombin and Factor V mutations in women with a history of thrombosis during pregnancy and puerperium. N Engl J Med 2000; 342: 374-80.
- 24. Rotenberg SP. Increasing the dietary intake of folate: Pros and cons. Semin Hematol 1999; 36: 65-74
- 25. Greer IA. The challange of thrombophilia in maternal and fetal medicine. N Engl J Med 2000; 342: 424-5.
- 26. Lockwood CJ. Heritable coagulopathies in preg¬nancy. Obstet Gynecol Surv 1999; 54: 754-65.
- 27. Qure I, Bellet H, Hoffet M, et al. A woman with five consecutive fetal deaths: Case report and retrospective analysis of hyperhomocysteinemia prevalance in 100 consecutive women with recurrent miscarriages. Fertil Steril 1998; 69:152-4.
- 28. Dahlman T. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993; 168:1265-70.
- 29. Pagliaro P, Arrigoni L, Muggiasca ML, et al. Primary thrombocytemia and pregnancy: Treatment and outcome in fifteen cases. Am J Hematol 1996; 53: 6-10.
- 30. Griesshamer M, Bangerter M, VanVliet HHDM, et al. Aspirin in essential thrombocytemia: Status quo and quo vadis. Sem Thromb Hemost 1997; 3: 371-7.
- 31. Eliyahu S, Shalev E. Essential thrombocytemia during pregnancy. Obstet Gynecol Surv 1997; 4: 243-7.
- 32. Elliot MA, Tefferi A. Interferon-a therapy in polycythemia vera and essential thrombocytemia. Sem Thromb Hemost 23: 463-72.
- 33. Solal-Celigney P, Tertian G, Fernandez H. Pregnancy and paroxymal nocturnal hemoglobinuria. Arch Intern Med 1988; 148: 593-8.
- 34. Pwood JL. Paroxymal nocturnal hemoglobinuria and pregnancy. Lancet 1986; 2: 109-13.
| APA | SUCAK T, SUCAK A (2001). Gebelik ve hiperkoagülabilite. , 40 - 47. |
| Chicago | SUCAK Türköz Gülsan,SUCAK Ayhan Gebelik ve hiperkoagülabilite. (2001): 40 - 47. |
| MLA | SUCAK Türköz Gülsan,SUCAK Ayhan Gebelik ve hiperkoagülabilite. , 2001, ss.40 - 47. |
| AMA | SUCAK T,SUCAK A Gebelik ve hiperkoagülabilite. . 2001; 40 - 47. |
| Vancouver | SUCAK T,SUCAK A Gebelik ve hiperkoagülabilite. . 2001; 40 - 47. |
| IEEE | SUCAK T,SUCAK A "Gebelik ve hiperkoagülabilite." , ss.40 - 47, 2001. |
| ISNAD | SUCAK, Türköz Gülsan - SUCAK, Ayhan. "Gebelik ve hiperkoagülabilite". (2001), 40-47. |
| APA | SUCAK T, SUCAK A (2001). Gebelik ve hiperkoagülabilite. Türkiye Tıp Dergisi Dahili Tıp Bilimleri, 8(1), 40 - 47. |
| Chicago | SUCAK Türköz Gülsan,SUCAK Ayhan Gebelik ve hiperkoagülabilite. Türkiye Tıp Dergisi Dahili Tıp Bilimleri 8, no.1 (2001): 40 - 47. |
| MLA | SUCAK Türköz Gülsan,SUCAK Ayhan Gebelik ve hiperkoagülabilite. Türkiye Tıp Dergisi Dahili Tıp Bilimleri, vol.8, no.1, 2001, ss.40 - 47. |
| AMA | SUCAK T,SUCAK A Gebelik ve hiperkoagülabilite. Türkiye Tıp Dergisi Dahili Tıp Bilimleri. 2001; 8(1): 40 - 47. |
| Vancouver | SUCAK T,SUCAK A Gebelik ve hiperkoagülabilite. Türkiye Tıp Dergisi Dahili Tıp Bilimleri. 2001; 8(1): 40 - 47. |
| IEEE | SUCAK T,SUCAK A "Gebelik ve hiperkoagülabilite." Türkiye Tıp Dergisi Dahili Tıp Bilimleri, 8, ss.40 - 47, 2001. |
| ISNAD | SUCAK, Türköz Gülsan - SUCAK, Ayhan. "Gebelik ve hiperkoagülabilite". Türkiye Tıp Dergisi Dahili Tıp Bilimleri 8/1 (2001), 40-47. |
